Topical Treatment for Cutaneous Leishmaniasis: Dermato-Pharmacokinetic Lead Optimization of Benzoxaboroles.

about

Local Skin Inflammation in Cutaneous Leishmaniasis as a Source of Variable Pharmacokinetics and Therapeutic Efficacy of Liposomal Amphotericin B

P2860

Q58701149-8AD8588B-6019-44CC-97FD-908F641AFE18

P2860

Topical Treatment for Cutaneous Leishmaniasis: Dermato-Pharmacokinetic Lead Optimization of Benzoxaboroles.

Item

http://www.wikidata.org/entity/Q53080458

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Topical Treatment for Cutaneou ...... ptimization of Benzoxaboroles.

@en

Topical Treatment for Cutaneou ...... ptimization of Benzoxaboroles.

@nl

type

Item

label

Topical Treatment for Cutaneou ...... ptimization of Benzoxaboroles.

@en

Topical Treatment for Cutaneou ...... ptimization of Benzoxaboroles.

@nl

prefLabel

Topical Treatment for Cutaneou ...... ptimization of Benzoxaboroles.

@en

Topical Treatment for Cutaneou ...... ptimization of Benzoxaboroles.

@nl

P1476

Topical Treatment for Cutaneou ...... ptimization of Benzoxaboroles.

@en

P2093

Deirdre Hauser

http://www.w3.org/2001/XMLSchema#string

Eric Gaukel

http://www.w3.org/2001/XMLSchema#string

Jacob J Plattner

http://www.w3.org/2001/XMLSchema#string

Katrien Van Bocxlaer

http://www.w3.org/2001/XMLSchema#string

Robert T Jacobs

http://www.w3.org/2001/XMLSchema#string

Ryan Randolph

http://www.w3.org/2001/XMLSchema#string

Sara Schock

http://www.w3.org/2001/XMLSchema#string

Seong Hee Park

http://www.w3.org/2001/XMLSchema#string

Simon L Croft

http://www.w3.org/2001/XMLSchema#string

Stephen A Wring

http://www.w3.org/2001/XMLSchema#string

P2860

Leishmaniasis worldwide and global estimates of its incidence

Importance of relating efficacy measures to unbound drug concentrations for anti-infective agents

Discovery of a potent benzoxaborole-based anti-pneumococcal agent targeting leucyl-tRNA synthetase

The 500 Dalton rule for the skin penetration of chemical compounds and drugs

The increase in risk factors for leishmaniasis worldwide

Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport

Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin

In vitro and in vivo miltefosine susceptibility of a Leishmania amazonensis isolate from a patient with diffuse cutaneous leishmaniasis

Drug discovery algorithm for cutaneous leishmaniasis.

New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resource.

P31

scholarly article

P356

10.1128/AAC.02419-17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29507073

http://www.w3.org/2001/XMLSchema#string

P932

5923108

http://www.w3.org/2001/XMLSchema#string

Topical Treatment for Cutaneous Leishmaniasis: Dermato-Pharmacokinetic Lead Optimization of Benzoxaboroles.

about

P2860

P2860

Topical Treatment for Cutaneous Leishmaniasis: Dermato-Pharmacokinetic Lead Optimization of Benzoxaboroles.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P577

P698

P932